pharmaceuticals
pharmaceuticals Articles
Theravance Biopharma has announced that the FDA approved its supplemental New Drug Application for Vibativ (telavancin) to expand the product's label.
Published:
Last Updated:
Horizon Pharma reported better-than-expected first-quarter financial results before the markets opened on Monday.
Published:
Last Updated:
When Endo International reported its first-quarter financial results on Thursday, earnings vastly underwhelmed, and analysts definitely had something to say about it.
Published:
Last Updated:
Several big FDA decisions should be coming up in the June quarter for the likes of AstraZeneca and Sarepta Therapeutics.
Published:
Last Updated:
Endo International reported mixed first-quarter financial results after the markets closed on Thursday.
Published:
Last Updated:
Drug giant Merck reported mixed first-quarter 2016 results before markets opened Thursday morning.
Published:
Last Updated:
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates for generic...
Published:
Last Updated:
Credit Suisse's new Neutral rating on Teva Pharmaceutical Industries actually comes with significant upside.
Published:
Last Updated:
Viamet Pharmaceuticals intends to price more than 5 million shares within the range of $14 to $16 per share for an initial public offering valued up to almost $105 million.
Published:
Last Updated:
Infectious diseases always have been a hot topic in biotech, but over the past half decade more capital has been drawn into the space.
Published:
Last Updated:
Pfizer is scheduled to report its first-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
One portfolio manager on CNBC noted that Vertex could end up being an acquisition target ahead, without mentioning any specifics.
Published:
Last Updated:
AbbVie reported its first-quarter financial results and guidance before the markets opened on Thursday.
Published:
Last Updated:
The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
If Moody's is correct, pharmaceutical earnings will keep growing for at least the next year and a half.
Published:
Last Updated: